search
Back to results

Heart Rate Variability Biofeedback Training in Psychogenic Disorders (ECoDys)

Primary Purpose

Psychogenic Dystonia

Status
Recruiting
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Heart rate variability biofeedback training (Symbiocenter)
psychoeducation session
Sponsored by
University Hospital, Montpellier
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Psychogenic Dystonia focused on measuring Cervical dystonia, Psychogenic disorder, Heart Rate Variability, Functional neurosurgery

Eligibility Criteria

18 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion criteria:

  • Age 18 to 75
  • Responding to somatoform disorder characteristics as described in ICD-10 (F45: "The onset of physical symptoms associated with an insistent medical quest, persisting despite repeated negative assessments and statements by physicians that the symptoms have no organic basis. If there is a genuine physical disorder, it does not account for the nature or severity of the symptoms, or the distress or concerns of the subject. The multidisciplinary team will determine whether or not the diagnosis of conversion disorder (disorder with functional neurological symptoms) of the DSMV (300.11) [ICD-10 equivalent: F44.4 "dissociative disorder with abnormal movements"] is associated with the diagnosis of conversion disorder (disorder with functional neurological symptoms) of the DSMV (300.11) [ICD-10 equivalent: F44.4 "dissociative disorder with abnormal movements"], selected by the multidisciplinary team after a phase 1 assessment.
  • Patient benefiting from a social security scheme

Exclusion criteria:

  • Simulation identified with obvious search for secondary benefit according to the ICD-10 classification ( Z76.5 Simulator: Person pretending to be ill (with obvious motivation"), or DSM-V(V65.2)
  • Any other specific PAT-specific CEP (botulinum toxin, psychotherapy and/or relaxation provided by a professional (CBT, ACT, Mindfulness, etc.)) scheduled within 6 months, with the exception of the usual analgesics (Tier I or II)Presenting significant cognitive impairment (MoCa test ≤ 24/30),
  • Absence foreseeable at least 30% of the sessions,
  • Lack of informed consent.
  • Pregnancy or planned pregnancy during the study period, Pregnant or breastfeeding women
  • Major protected by law or patient under guardianship or curatorship
  • Participation in other ongoing research

Sites / Locations

  • Montpellier University HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Other

Arm Label

HRV biofeedback training

control

Arm Description

During the inclusion visit, all patients will benefit from a psychoeducation session supervised by the psychologist. This group of patients will also benefit from the HRV biofeedback training.

During the inclusion visit, all patients will benefit from a psychoeducation session supervised by the psychologist.

Outcomes

Primary Outcome Measures

Variability of the cervical dystonia at 6 months
Measured by the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) scale. The total score is 0 (better outcome) to 85 (worse outcome)

Secondary Outcome Measures

Variability of the cervical dystonia at 3 months
Measured by the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) scale. The total score is 0 (better outcome) to 85 (worse outcome)
Quality of life assessment in cervical dystonia at 3 months
Measured by the Craniocervical Dystonia Questionnaire (CDQ24) scale
Quality of life assessment in cervical dystonia at 6 months
Measured by the Craniocervical Dystonia Questionnaire (CDQ24) scale
Quality of life assessment at 3 months
Measured by SF-36 scale
Quality of life assessment at 6 months
Measured by SF-36 scale
Assessment of the severity of depression at 3 month
Measured by Beck Depression Inventory (BDI-II) scale
Assessment of the severity of depression at 6 month
Measured by the Beck Depression Inventory (BDI-II) scale
Assessment of the anxiety at 3 month
Measured by the State-Trait Anxiety Inventory (STAI A & B) scale
Assessment of the anxiety at 6 month
Measured by the State-Trait Anxiety Inventory (STAI A & B) scale
satisfaction with the care
satisfaction's VAS
medical nomadism index
The index of "presumed nomadism" is the difference between the number of different doctors consulted and the number of different specialties of these same doctors. Any patient whose index is ≥ 3 over a period of 6 months is presumed nomadic.

Full Information

First Posted
September 8, 2020
Last Updated
May 6, 2021
Sponsor
University Hospital, Montpellier
search

1. Study Identification

Unique Protocol Identification Number
NCT04777825
Brief Title
Heart Rate Variability Biofeedback Training in Psychogenic Disorders
Acronym
ECoDys
Official Title
Evaluation of the Effectiveness of a Heart Rate Variability Biofeedback Training in the Management of Dysfunctional (Somatoform) Disorders
Study Type
Interventional

2. Study Status

Record Verification Date
May 2021
Overall Recruitment Status
Recruiting
Study Start Date
April 30, 2021 (Actual)
Primary Completion Date
April 2024 (Anticipated)
Study Completion Date
April 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Montpellier

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
To study whether Heart Rate Variability (HRV) biofeedback training can improve abnormal head posture and painful symptomatology in patients with "cervical dystonia" not selected for DBS after extensive screening in a specialized unit but diagnosed " dysfunctional ". Patients of the respiratory coherence group will receive HRV biofeedback training for 12 sessions during a 6 months-period. The hypothesis is that this kind of physiological noninvasive therapy increasing coherence respiratory, will reduce pain and patient's complain about their psychogenic abnormal head posture. Improvement of anxiety, depression and quality of life are expected.
Detailed Description
Patients presenting with an isolated abnormal head posture, first diagnosed as cervical dystonia, demonstrated in fact, after neurological screening, to be of psychogenic origine. These patients are not candidate for functional surgery and, furthermore, usually refuse psychotherapy leading them to medical nomadism. This study proposes to evaluate the efficacy of an innovative intervention program based on Heart Rate Variability (HRV) biofeedback that promotes self-regulatory skills in dysfunctional movement disorders (DMD) patients in order to improve their condition and symptomatology. Heart rate is under the control of efferent sympathetic and vagal activities directed to the sinus node, which are modulated by central brain stem (vasomotor and respiratory centers) and peripheral oscillators (oscillation in arterial pressure and respiratory movements). Spectral analysis of HRV is a reliable quantitative method for analyzing the modulatory effects of neural mechanisms on the sinus node. Several biofeedback protocols and assistive electronic technologies, such as proposed by SymbioCenter©, exist to enhance increase HRV and synchronize respiration with the heart rhythm. HRV biofeedback training appears to be an opportunity in the patient's management in order of preventing medical overconsuming. It is offering a safe and non-pharmacological alternative approach managed by a multidisciplinary team in a functional neurosurgery unit. It is expected that developing respiratory coherence in these patients will improve their painful symptomatology.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Psychogenic Dystonia
Keywords
Cervical dystonia, Psychogenic disorder, Heart Rate Variability, Functional neurosurgery

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
40 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
HRV biofeedback training
Arm Type
Experimental
Arm Description
During the inclusion visit, all patients will benefit from a psychoeducation session supervised by the psychologist. This group of patients will also benefit from the HRV biofeedback training.
Arm Title
control
Arm Type
Other
Arm Description
During the inclusion visit, all patients will benefit from a psychoeducation session supervised by the psychologist.
Intervention Type
Other
Intervention Name(s)
Heart rate variability biofeedback training (Symbiocenter)
Intervention Description
12 sessions of thirty minutes. Patients will participate through several serious game associated with HRV biofeedback training
Intervention Type
Other
Intervention Name(s)
psychoeducation session
Intervention Description
Each patient will therefore be presented individually with a Powerpoint consisting of 35 slides divided into 4 sub-sections explaining in a fun and educational format the physiological model of stress, the respiratory function and its benefits, presentation of various relaxation techniques and recommendations for reading (stress management, letting go, mindfulness meditation) and other tools to help relaxation (smartphone applications).
Primary Outcome Measure Information:
Title
Variability of the cervical dystonia at 6 months
Description
Measured by the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) scale. The total score is 0 (better outcome) to 85 (worse outcome)
Time Frame
6 months
Secondary Outcome Measure Information:
Title
Variability of the cervical dystonia at 3 months
Description
Measured by the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) scale. The total score is 0 (better outcome) to 85 (worse outcome)
Time Frame
3 months
Title
Quality of life assessment in cervical dystonia at 3 months
Description
Measured by the Craniocervical Dystonia Questionnaire (CDQ24) scale
Time Frame
3 months
Title
Quality of life assessment in cervical dystonia at 6 months
Description
Measured by the Craniocervical Dystonia Questionnaire (CDQ24) scale
Time Frame
6 months
Title
Quality of life assessment at 3 months
Description
Measured by SF-36 scale
Time Frame
3 months
Title
Quality of life assessment at 6 months
Description
Measured by SF-36 scale
Time Frame
6 months
Title
Assessment of the severity of depression at 3 month
Description
Measured by Beck Depression Inventory (BDI-II) scale
Time Frame
3 months
Title
Assessment of the severity of depression at 6 month
Description
Measured by the Beck Depression Inventory (BDI-II) scale
Time Frame
6 months
Title
Assessment of the anxiety at 3 month
Description
Measured by the State-Trait Anxiety Inventory (STAI A & B) scale
Time Frame
3 months
Title
Assessment of the anxiety at 6 month
Description
Measured by the State-Trait Anxiety Inventory (STAI A & B) scale
Time Frame
6 months
Title
satisfaction with the care
Description
satisfaction's VAS
Time Frame
6 months
Title
medical nomadism index
Description
The index of "presumed nomadism" is the difference between the number of different doctors consulted and the number of different specialties of these same doctors. Any patient whose index is ≥ 3 over a period of 6 months is presumed nomadic.
Time Frame
6 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion criteria: Age 18 to 75 Responding to somatoform disorder characteristics as described in ICD-10 (F45: "The onset of physical symptoms associated with an insistent medical quest, persisting despite repeated negative assessments and statements by physicians that the symptoms have no organic basis. If there is a genuine physical disorder, it does not account for the nature or severity of the symptoms, or the distress or concerns of the subject. The multidisciplinary team will determine whether or not the diagnosis of conversion disorder (disorder with functional neurological symptoms) of the DSMV (300.11) [ICD-10 equivalent: F44.4 "dissociative disorder with abnormal movements"] is associated with the diagnosis of conversion disorder (disorder with functional neurological symptoms) of the DSMV (300.11) [ICD-10 equivalent: F44.4 "dissociative disorder with abnormal movements"], selected by the multidisciplinary team after a phase 1 assessment. Patient benefiting from a social security scheme Exclusion criteria: Simulation identified with obvious search for secondary benefit according to the ICD-10 classification ( Z76.5 Simulator: Person pretending to be ill (with obvious motivation"), or DSM-V(V65.2) Any other specific PAT-specific CEP (botulinum toxin, psychotherapy and/or relaxation provided by a professional (CBT, ACT, Mindfulness, etc.)) scheduled within 6 months, with the exception of the usual analgesics (Tier I or II)Presenting significant cognitive impairment (MoCa test ≤ 24/30), Absence foreseeable at least 30% of the sessions, Lack of informed consent. Pregnancy or planned pregnancy during the study period, Pregnant or breastfeeding women Major protected by law or patient under guardianship or curatorship Participation in other ongoing research
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Emily SANREY, MSc
Phone
467337445
Ext
+33
Email
e-sanrey@chu-montpellier.fr
First Name & Middle Initial & Last Name or Official Title & Degree
Valérie GIL, CTA
Phone
467337464
Ext
+33
Email
v-gil@chu-montpellier.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Philippe COUBES, MD, PhD
Organizational Affiliation
Montpellier University Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Montpellier University Hospital
City
Montpellier
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Emily SANREY, MSc
Phone
467337445
Ext
+33
Email
e-sanrey@chu-montpellier.fr
First Name & Middle Initial & Last Name & Degree
Valérie GIL, CTA
Phone
467337464
Ext
+33
Email
v-gil@chu-montpellier.fr

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Heart Rate Variability Biofeedback Training in Psychogenic Disorders

We'll reach out to this number within 24 hrs